Antonio Ceriello Selected Research

Hyperglycemia

3/2022	Effect of Hyperglycemia on COVID-19 Outcomes: Vaccination Efficacy, Disease Severity, and Molecular Mechanisms.
1/2021	DPP-4 Inhibitors Have Different Effects on Endothelial Low-Grade Inflammation and on the M1-M2 Macrophage Polarization Under Hyperglycemic Conditions.
7/2020	Review of methods for detecting glycemic disorders.
1/2020	Issues for the management of people with diabetes and COVID-19 in ICU.
10/2018	Real-world use of self-monitoring of blood glucose in people with type 2 diabetes: an urgent need for improvement.
2/2018	Teneligliptin enhances the beneficial effects of GLP-1 in endothelial cells exposed to hyperglycemic conditions.
6/2017	The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory.
1/2017	Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative.
8/2016	The evolving frontier of diabetes therapy: The renaissance of glycemology.
4/2016	The simultaneous control of hyperglycemia and GLP-1 infusion normalize endothelial function in type 1 diabetes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio Ceriello Research Topics

Disease

97	Type 2 Diabetes Mellitus (MODY) 05/2022 - 02/2002
51	Hyperglycemia 03/2022 - 04/2002
22	Diabetes Complications 01/2021 - 08/2002
22	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 05/2004
17	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 03/2005
16	Inflammation (Inflammations) 06/2022 - 05/2005
16	Hypoglycemia (Reactive Hypoglycemia) 02/2020 - 01/2007
10	Heart Failure 01/2022 - 01/2007
9	COVID-19 06/2022 - 01/2020
9	Insulin Resistance 05/2021 - 05/2004
9	Albuminuria 11/2020 - 09/2015
9	Hypertension (High Blood Pressure) 11/2020 - 02/2008
9	Glucose Intolerance 07/2020 - 10/2002
8	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 03/2003
8	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 05/2006
6	Body Weight (Weight, Body) 01/2021 - 10/2008
5	Overweight 01/2022 - 09/2008
5	Atherosclerosis 01/2020 - 01/2005
5	Myocardial Infarction 07/2011 - 12/2004
4	Weight Loss (Weight Reduction) 01/2022 - 01/2008
4	Thrombosis (Thrombus) 01/2021 - 02/2013
4	Kidney Diseases (Kidney Disease) 01/2021 - 11/2015
4	Weight Gain 03/2020 - 02/2011
4	Chronic Renal Insufficiency 12/2019 - 07/2016
4	Diabetes Mellitus 12/2017 - 11/2007
4	Obesity 02/2015 - 01/2008
3	Abdominal Obesity 01/2020 - 04/2008
3	Hyperlipidemias (Hyperlipidemia) 08/2019 - 10/2004
3	Neoplasms (Cancer) 12/2018 - 12/2010
3	Necrosis 03/2018 - 05/2006
3	Chronic Disease (Chronic Diseases) 05/2008 - 08/2006
2	Peripheral Arterial Disease 02/2022 - 03/2007
2	Acute Coronary Syndrome 01/2021 - 07/2011
2	Prediabetic State (Prediabetes) 07/2020 - 02/2015
2	Periodontitis 03/2018 - 01/2018

Drug/Important Bio-Agent (IBA)

68	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 10/2002
36	Insulin (Novolin)FDA Link 03/2022 - 08/2002
21	Blood Glucose (Blood Sugar)IBA 01/2022 - 05/2004
16	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 02/2005
16	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 03/2011
13	AntioxidantsIBA 06/2017 - 10/2002
12	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 01/2017
12	LipidsIBA 01/2021 - 05/2006
11	Triglycerides (Triacylglycerol)IBA 08/2019 - 01/2007
10	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018 - 05/2006
9	LDL CholesterolIBA 02/2022 - 01/2007
9	oxidized low density lipoproteinIBA 01/2020 - 01/2007
9	HDL CholesterolIBA 08/2019 - 01/2007
8	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 11/2018
8	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020 - 01/2008
8	Free RadicalsIBA 02/2008 - 05/2003
8	Superoxides (Superoxide)IBA 02/2008 - 05/2003
7	Proteins (Proteins, Gene)FDA Link 03/2022 - 08/2006
7	CarbohydratesIBA 05/2021 - 08/2006
7	3-nitrotyrosineIBA 11/2014 - 04/2002
6	Uric Acid (Urate)IBA 01/2021 - 11/2015
6	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2017
6	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 10/2016
6	Liraglutide FDA Link 02/2020 - 02/2012
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 05/2005
6	Interleukin-6 (Interleukin 6)IBA 11/2014 - 10/2002
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2013
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 03/2003
5	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2019 - 01/2006
5	Vitamin E FDA LinkGeneric 03/2007 - 05/2003
5	Peroxynitrous Acid (Peroxynitrite)IBA 05/2006 - 08/2002
4	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 01/2021 - 06/2017
4	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021 - 09/2010
4	Pharmaceutical PreparationsIBA 01/2020 - 05/2006
4	InterleukinsIBA 03/2018 - 05/2006
4	Hemoglobins (Hemoglobin)IBA 09/2015 - 01/2007
4	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2013 - 07/2007
4	Oxygen (Dioxygen)IBA 01/2007 - 05/2003
3	mesoglycanIBA 11/2021 - 10/2013
3	AlbuminsIBA 01/2021 - 01/2016
3	omega-Chloroacetophenone (Mace)IBA 01/2021 - 01/2020
3	OsteoprotegerinIBA 12/2020 - 01/2018
3	SodiumIBA 01/2020 - 07/2014
3	Pioglitazone (Actos)FDA Link 01/2020 - 02/2005
3	C-Reactive ProteinIBA 01/2020 - 12/2004
3	NF-kappa B (NF-kB)IBA 03/2018 - 01/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2016 - 10/2002
3	Adenosine Triphosphate (ATP)IBA 05/2007 - 10/2004
2	Nonesterified Fatty Acids (NEFA)IBA 01/2021 - 01/2007
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2021 - 09/2010
2	C-PeptideIBA 12/2020 - 01/2020
2	empagliflozinIBA 10/2020 - 01/2016
2	AngiotensinsIBA 01/2020 - 10/2004
2	Transcription Factors (Transcription Factor)IBA 12/2019 - 01/2007
2	Glucagon-Like Peptide-1 ReceptorIBA 12/2019 - 09/2016
2	CholesterolIBA 01/2019 - 03/2014
2	LigandsIBA 03/2018 - 01/2018

Therapy/Procedure

32	Therapeutics 01/2022 - 05/2003
24	Glycemic Control 03/2022 - 12/2004
5	Injections 01/2022 - 11/2007
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2008
3	Mediterranean Diet 11/2014 - 05/2008
2	Surgical Amputation (Amputations) 01/2020 - 05/2008
2	Contraindications 01/2020 - 06/2013
2	Secondary Prevention 01/2020 - 08/2010